Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2003
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002047706A3 Selective cox-2 inhibition from plant extracts
12/31/2003WO2002047615A3 Oral compositions and use thereof
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002023199A8 Method, system, apparatus and device for discovering and preparing chemical compounds
12/31/2003WO2001006984A3 Small molecules useful in the treatment of inflammatory disease
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464878A Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1463743A Capsule possessing antisenescent and spot dispelling effect and method for making the same
12/31/2003CN1463705A Panaxoside, lecithine refreshing and brain tonic and process for producing the same
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132818C 用作抗病毒剂的4－氧代－1,4－二氢－3－喹啉甲酰胺 As antiviral agents 4-oxo-1,4-dihydro-3-quinoline carboxamide
12/31/2003CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound
12/31/2003CN1132631C Veterinary medicine for treating infective serositis of duck and its preparing process
12/31/2003CN1132587C Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
12/31/2003CN1132581C Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003CA2490626A1 Prodrug, medicinal utilization thereof and process for producing the same
12/31/2003CA2490526A1 Hetero-bicyclic compounds
12/31/2003CA2490452A1 .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan
12/31/2003CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490365A1 Quick dissolve compositions and tablets based thereon
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2489947A1 Treatment of human multiple myeloma by curcumin
12/31/2003CA2489911A1 Pasteurisation process for microbial cells and microbial oil
12/31/2003CA2489905A1 Osteopontin, oligodendrocytes and myelination
12/31/2003CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003CA2488311A1 Combination treatment for depression and anxiety by nk1 and nk3 antagonists
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003CA2485537A1 Novel compounds, their use and preparation
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/30/2003US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds
12/30/2003US6670481 Oxiranecarboxylic acids for the treatment of diabetes
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670392 Administering vitamin e and selenium, or compound thereof
12/30/2003US6670388 Antibiotics for Gram positive and Gram negative bacteria; 5-(2-chloro- 5-hydroxybenzyloxy)-1-((2-thiophen-3-yl)ethyl) -1H-indole-2-carboxylic acid; 1-((6-chlorobenzo(1,3)dioxol-5 -yl)methyl)-5-(2-chloro-5-hydroxybenzyloxy)-1H-indole-2-acid
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670368 Pyrimidine compounds with pharmaceutical activity
12/30/2003US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists
12/30/2003US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670356 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
12/30/2003US6670353 Oxime-group containing oestrone sulphatase inhibitors
12/30/2003US6670349 Asthma
12/30/2003US6670348 Antitumor geldanamycins
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2301086C Animal feed containing carboxylic acids
12/30/2003CA2291931C Isochroman compounds and their production process
12/30/2003CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate
12/30/2003CA2266015C Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/30/2003CA2158331C Injection vessel and solution-enclosed injection vessel in use thereof
12/30/2003CA2144416C Method and composition for the treatment of hair loss
12/30/2003CA2099970C Composition for curing sjoegren syndrome disease
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/28/2003CA2433237A1 Use of chloroquine, hydroxy chloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and nonnucleosidic reverse transcriptase inhibitors and to proteases inhibitors
12/25/2003WO2003106461A2 Pseudopolymorphic forms of a hiv protease inhibitor
12/25/2003WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236408 Estrogenic compounds as anti-mitotic agents
12/25/2003US20030236406 Amination forming a benzylammonium methyl phenoxy 5-tetrahydrobenzothiepine; apical sodium co- dependent bile acid transporter inhibitors, anticholesterol agents
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236304 Fluorobenzamides and uses thereof
12/25/2003US20030236295 Tricylic indole compounds having affinity for serotonin receptor
12/25/2003US20030236294 Anticancer agents
12/25/2003US20030236289 Antiinflammatory agents; analgesics; antipyretics; cyclooxygenase inhibitor
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1564